Project Details
Description
We are in collaboration with Qral Ventures to characterize the in vitro pharmacology of MEAN for multiple indications and molecular targets. The fund will be used strictly for that purpose.
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/22 → 5/10/22 |
Funding
- Qral Ventures LLC (QV AGMT 4-5-22)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.